Bitcoin groundbreakers share personal stories of how Bitcoin is changing lives for the better. Host Mauricio Di Bartolomeo, co-founder and CSO of Ledn, speaks with leading Bitcoin voices, entrepreneurs, and human rights advocates to hear their unique journey and practical real-world examples of how Bitcoin has made a positive impact in their lives. Brought to you by Ledn, a leading financial services company built for Bitcoin & digital assets. Ledn offers a suite of lending, saving and tradi ...
…
continue reading
Indhold leveret af Proactive Investors. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Proactive Investors eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !
Gå offline med appen Player FM !
Frontier IP: The Vaccine Group's Jeremy Salt on £400k Innovate UK Smart grant for animal health
MP3•Episode hjem
Manage episode 445738243 series 2891889
Indhold leveret af Proactive Investors. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Proactive Investors eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Frontier IP Group PLC (AIM:FIPP) portfolio company The Vaccine Group (TVG) has secured over £400,000 in funding through an Innovate UK Smart Grant. CEO Jeremy Salt told Proactive's Stephen Gunnion the funding will support the development of novel herpesvirus vaccine technology aimed at combating two critical cattle diseases: bovine respiratory syncytial virus (BRSV) and lumpy skin disease. Salt highlighted the commercial importance of these diseases, particularly noting that BRSV impacts nearly 2 million calves annually in the UK alone, costing the industry £54 million per year. This grant will allow The Vaccine Group to move from laboratory testing to real-world animal trials in collaboration with the Animal and Plant Health Agency (APHA) and The Pirbright Institute. Salt also shared updates on other key projects, including the company's efforts in developing vaccines for companion animals such as cats, dogs, and horses, as well as an ongoing Innovate UK grant to target Streptococcus suis in pigs. Don't forget to give this video a like, subscribe to the Proactive channel, and enable notifications to stay updated on more interviews like this one!" #VaccineDevelopment #AnimalHealth #BovineDiseases #InnovateUK #LumpySkinDisease #BRSV #CompanionAnimalVaccines #JeremySalt #TheVaccineGroup #FrontierIP #AnimalVaccines #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
605 episoder
MP3•Episode hjem
Manage episode 445738243 series 2891889
Indhold leveret af Proactive Investors. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Proactive Investors eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Frontier IP Group PLC (AIM:FIPP) portfolio company The Vaccine Group (TVG) has secured over £400,000 in funding through an Innovate UK Smart Grant. CEO Jeremy Salt told Proactive's Stephen Gunnion the funding will support the development of novel herpesvirus vaccine technology aimed at combating two critical cattle diseases: bovine respiratory syncytial virus (BRSV) and lumpy skin disease. Salt highlighted the commercial importance of these diseases, particularly noting that BRSV impacts nearly 2 million calves annually in the UK alone, costing the industry £54 million per year. This grant will allow The Vaccine Group to move from laboratory testing to real-world animal trials in collaboration with the Animal and Plant Health Agency (APHA) and The Pirbright Institute. Salt also shared updates on other key projects, including the company's efforts in developing vaccines for companion animals such as cats, dogs, and horses, as well as an ongoing Innovate UK grant to target Streptococcus suis in pigs. Don't forget to give this video a like, subscribe to the Proactive channel, and enable notifications to stay updated on more interviews like this one!" #VaccineDevelopment #AnimalHealth #BovineDiseases #InnovateUK #LumpySkinDisease #BRSV #CompanionAnimalVaccines #JeremySalt #TheVaccineGroup #FrontierIP #AnimalVaccines #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
605 episoder
Alle episoder
×Velkommen til Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.